DUBLIN, June 9, 2021 / PRNewswire / – The “Veterinary Oncology – Global Market Trajectory and Analysis” report was added to ResearchAndMarkets.com offer.
In the midst of the COVID-19 crisis, the global veterinary oncology market is estimated at 215.4 million US dollars in 2020, is expected to reach a revised size of US $ 400.2 million by 2027, with a CAGR of 9.3% over the analysis period 2020-2027.
Radiology, one of the segments analyzed in the report, is expected to register a CAGR of 8.6% and reach US $ 115.9 million at the end of the analysis period. After an initial analysis of the business implications of the pandemic and the induced economic crisis, the growth of the Chemotherapy segment is readjusted to a revised CAGR of 10% for the next 7-year period.
The US market is estimated at $ 58.3 million, while China is expected to grow at 12.4% CAGR
The veterinary oncology market in the United States is estimated at US $ 58.3 million in the year 2020. China, the world’s second-largest economy, is expected to reach a projected market size of US $ 83.1 million by 2027, with a CAGR of 12.2% over the analysis period of 2020 to 2027. Other notable geographies include Japan and Canada, each forecasts growth of 6.3% and 7.9% respectively over the period 2020-2027. In Europe, Germany is expected to grow at around 7.2% CAGR.
Immunotherapy segment to register 9.7% CAGR
In the global immunotherapy segment, United States, Canada, Japan, China and Europe will lead to the estimated 9% CAGR for this segment. These regional markets representing a combined market size of US $ 32.4 million in 2020 will reach a projected size of US $ 59.3 million before the end of the analysis period. China will remain among the most dynamic of this group of regional markets. Led by countries such as Australia, India, and South Korea, the market of Asia Pacific should reach US $ 57.1 million by 2027, while Latin America will increase at a CAGR of 11.1% throughout the analysis period.
Some competitors (40 in total):
- Accuray Incorporated
- Boehringer Ingelheim International GmbH
- Karyopharm Therapeutics, Inc.
- Morphogenesis, Inc.
- Nippon Zenyaku Kogyo Co., Ltd.
- PetCure Oncology
- Regeneus Ltd.
- Varian Medical System, Inc.
Main topics covered:
1. MARKET OVERVIEW
- Overview of the influencer market
- Global market trajectories
- Impact of Covid-19 and an impending global recession
2. FOCUS ON CERTAIN PLAYERS
3. MARKET TRENDS AND FACTORS
4. WORLD MARKET PERSPECTIVE
III. MARKET ANALYSIS
- UNITED STATES
- REST OF EUROPE
- ASIA PACIFIC
- SOUTH KOREA
- REST OF ASIA PACIFIC
- LATIN AMERICA
- REST OF LATIN AMERICA
- MIDDLE EAST
- SAUDI ARABIA
- UNITED ARAB EMIRATES
- REST OF MIDDLE EAST
- Total number of profiled companies: 40
For more information on this report, visit https://www.researchandmarkets.com/r/8ftsxg
Research and markets
Laura Wood, senior
For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716
SOURCE Research and Markets